Bioclinic S.A.

The Oncology Department in Thessaloniki is running a broad portfolio of studies focused on neoplasms, especially advanced cancers where new treatment combinations are being explored to improve survival and disease control.

• Studies in non-small cell lung cancer, small cell lung cancer, and other respiratory tract cancers
• Research in melanoma, urothelial carcinoma, and head and neck squamous cell carcinoma
• Trials in gastric, gastroesophageal, and colorectal cancers

Much of the work is aimed at testing newer immunotherapy and targeted therapy approaches, while also comparing them with current standard treatments to better define effectiveness and safety.

A major part of the research at this site centers on respiratory tract diseases, with a strong emphasis on lung cancer and asthma. These studies are designed to improve treatment options for people with advanced or hard-to-treat disease.

• Advanced non-small cell lung cancer and other forms of NSCLC
• Extensive-stage small cell lung cancer
• Moderate to severe asthma with a focus on treatment tolerability

The trials in this area mainly evaluate whether new drug combinations can extend survival, slow progression, or offer a better balance of benefit and tolerability than existing care.

The site is also active in a wide range of cancer research beyond the lung, covering both common and rarer tumor types. Many of these studies focus on patients with advanced or metastatic disease who may have limited standard options.

• Melanoma and dedifferentiated liposarcoma
• Breast cancer, including hormone receptor-positive, HER2-negative disease
• Urothelial, head and neck, and gastroesophageal cancers

Research here often compares novel targeted and immune-based therapies with established treatments, with the goal of improving response rates, delaying progression, and expanding options for patients with difficult-to-treat tumors.

Clinical trials in digestive system diseases at Bioclinic S.A. include several studies in gastrointestinal cancers and related advanced malignancies. The focus is on identifying more effective treatment strategies for tumors affecting the stomach, colon, pancreas, and nearby organs.

• Colorectal cancer and metastatic colorectal cancer
• Gastric and gastroesophageal junction cancer
• Advanced pancreatic cancer with attention to preventing treatment-related complications

These trials aim to test new combinations, refine maintenance approaches, and support better long-term outcomes for patients living with advanced gastrointestinal cancers.